Latest News

Latest News

SUNSHINE BIOPHARMA REPORTS IMPROVED CASH POSITION IN 2021Q1 FILING

SUNSHINE BIOPHARMA REPORTS IMPROVED CASH POSITION IN 2021Q1 FILING

adminMay 13, 20216 min read

For Immediate Release May 13, 2021 Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development, and  commercialization of…

SUNSHINE BIOPHARMA UPGRADES COVID-19 PROVISIONAL PATENT APPLICATION  TO FULL PCT APPLICATION

SUNSHINE BIOPHARMA UPGRADES COVID-19 PROVISIONAL PATENT APPLICATION TO FULL PCT APPLICATION

adminMay 4, 20216 min read

For Immediate Release May 4, 2021 Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and  commercialization of…

RB CAPITAL INCREASES INVESTMENT IN SUNSHINE BIOPHARMA

RB CAPITAL INCREASES INVESTMENT IN SUNSHINE BIOPHARMA

adminApril 22, 20216 min read

For Immediate Release April 22, 2021 Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and  commercialization of…

SUNSHINE BIOPHARMA REPORTS FAVORABLE MTD RESULTS FOR COVID-19  TREATMENT

SUNSHINE BIOPHARMA REPORTS FAVORABLE MTD RESULTS FOR COVID-19 TREATMENT

adminApril 19, 20215 min read

For Immediate Release April 19, 2021 Montreal, Quebec, Canada — (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and commercialization of…

SUNSHINE BIOPHARMA REACHES $2,000,000+ FINANCING FOR CORONAVIRUS TREATMENT

SUNSHINE BIOPHARMA REACHES $2,000,000+ FINANCING FOR CORONAVIRUS TREATMENT

adminMarch 23, 20216 min read

For Immediate Release March 23, 2021 Montreal, Quebec, Canada — (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and commercialization of…

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT  APPLICATION EXTENDING PROTECTION OF Adva-27a IN EUROPE UNTIL 2033

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT APPLICATION EXTENDING PROTECTION OF Adva-27a IN EUROPE UNTIL 2033

adminMarch 11, 20216 min read

For Immediate Release March 11, 2021 Montreal, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of oncology…

SUNSHINE BIOPHARMA RECEIVES RECENTLY ORDERED NEW BATCH OF Adva-27a  AND INITIATES QA/QC TESTING

SUNSHINE BIOPHARMA RECEIVES RECENTLY ORDERED NEW BATCH OF Adva-27a AND INITIATES QA/QC TESTING

adminMarch 4, 20214 min read

For Immediate Release March 4, 2021 Montreal, Quebec, Canada — (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and  commercialization of…

SUNSHINE BIOPHARMA LAUNCHES eCOMMERCE STORE FOR ITS SCIENCE-BASED  NUTRITIONAL SUPPLEMENTS

SUNSHINE BIOPHARMA LAUNCHES eCOMMERCE STORE FOR ITS SCIENCE-BASED NUTRITIONAL SUPPLEMENTS

adminMarch 1, 20214 min read

For Immediate Release March 1, 2021 Montreal, Quebec, Canada — (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a leader in nutrition research and development today unveiled its new…

Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer  Compounds with The Stock Day Podcast

Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

adminFebruary 17, 20216 min read

For Immediate Release February 17, 2021 Phoenix, February 17th, 2021 (Newsfile Corp.) — The Stock Day Podcast welcomed  Sunshine Biopharma (SBFM)(“the Company”), a company engaged in the development of Adva-27a,…